Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (301-310 of 463) with videos related to

Pageof 47
Sort By:
Alimentary Pharmacology & Therapeutics|May 10, 2024
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' replyArta Aliu, Daan H C A Bosch, Daniel Keszthelyi, et al.
The American Journal of Gastroenterology|August 27, 2014
Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3Jean-Frederic Colombel, William J Sandborn, Subrata Ghosh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 25, 2021
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant DisabilityMaia Kayal, Ryan C Ungaro, Alexa Riggs, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2019
Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitisMaia Kayal, Michael Plietz, Marlana Radcliffe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2023
Preclinical Serological Signatures are Associated With Complicated Crohn's Disease Phenotype at DiagnosisRok Seon Choung, Francesca Petralia, Joana Torres, et al.
Cell Host & Microbe|April 17, 2020
Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative ColitisIrina Leonardi, Sudarshan Paramsothy, Itai Doron, et al.
Inflammatory Intestinal Diseases|June 14, 2021
What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing CountriesRichard B Gearry, Andrew M McCombie, Morten Vatn, et al.
International Journal of Colorectal Disease|September 13, 2019
Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample studyMaia Kayal, Aparna Saha, Priti Poojary, et al.
The New England Journal of Medicine|September 24, 2025
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative ColitisFabian Müller, Raja Atreya, Simon Völkl, et al.
BMJ Open|February 21, 2019
Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trialsShomron Ben-Horin, Yue Zhao, Jing Guo, et al.
Pageof 47

Showing results (301-310 of 463) with videos related to

Sort By:
Pageof 47
Alimentary Pharmacology & Therapeutics|May 10, 2024
Letter: Intestinal permeability accounting for ongoing gastrointestinal symptoms following endoscopic remission in IBD-Authors' replyArta Aliu, Daan H C A Bosch, Daniel Keszthelyi, et al.
The American Journal of Gastroenterology|August 27, 2014
Four-year maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3Jean-Frederic Colombel, William J Sandborn, Subrata Ghosh, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 25, 2021
Ileal Pouch Anal Anastomosis for the Management of Ulcerative Colitis Is Associated With Significant DisabilityMaia Kayal, Ryan C Ungaro, Alexa Riggs, et al.
Alimentary Pharmacology & Therapeutics|October 4, 2019
Endoscopic activity in asymptomatic patients with an ileal pouch is associated with an increased risk of pouchitisMaia Kayal, Michael Plietz, Marlana Radcliffe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 14, 2023
Preclinical Serological Signatures are Associated With Complicated Crohn's Disease Phenotype at DiagnosisRok Seon Choung, Francesca Petralia, Joana Torres, et al.
Cell Host & Microbe|April 17, 2020
Fungal Trans-kingdom Dynamics Linked to Responsiveness to Fecal Microbiota Transplantation (FMT) Therapy in Ulcerative ColitisIrina Leonardi, Sudarshan Paramsothy, Itai Doron, et al.
Inflammatory Intestinal Diseases|June 14, 2021
What Are the Most Challenging Aspects of Inflammatory Bowel Disease? An International Survey of Gastroenterologists Comparing Developed and Developing CountriesRichard B Gearry, Andrew M McCombie, Morten Vatn, et al.
International Journal of Colorectal Disease|September 13, 2019
Emergent colectomy rates decreased while elective ileal pouch rates were stable over time: a nationwide inpatient sample studyMaia Kayal, Aparna Saha, Priti Poojary, et al.
The New England Journal of Medicine|September 24, 2025
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative ColitisFabian Müller, Raja Atreya, Simon Völkl, et al.
BMJ Open|February 21, 2019
Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trialsShomron Ben-Horin, Yue Zhao, Jing Guo, et al.
Pageof 47